Funder: National Institutes of Health

Due Dates: July 2, 2025 (New/Renewal/Resubmission/Revision) | Nov 4, 2025 (New/Renewal/Resubmission/Revision) | Mar 4, 2026 (New/Renewal/Resubmission/Revision) | July 2, 2026 (New/Renewal/Resubmission/Revision) | Nov 2, 2026 (New/Renewal/Resubmission/Revision)

Funding Amounts: Up to $600,000 direct costs over 3 years; no more than $300,000 direct costs in any single year.

Summary: Supports short-term exploratory clinical trials in arthritis, musculoskeletal, and skin diseases to advance prevention, diagnosis, or treatment.

Key Information: Clinical trial is required; updated review criteria apply for due dates on or after Jan 25, 2025.